Evidence map›Paper›PMID 42088279›Full record

ArticleFood chemistry: X2026

Valorization of green tea residues through dual carboxymethylation-homogenization treatment for improved dietary fiber functionality.

Guihun Jiang, Karna Ramachandraiah, Xuehu Liu, Wenguang Zhang, Xiaoyu Feng, Xiaoyao Wang

Abstract read
In one paragraph

Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guihun JiangSchool of Public Health, Jilin Medical University, Jilin, 132013 Jilin, China.
Karna RamachandraiahDepartment of Biology, University of North Florida, Jacksonville, FL 32224, United States.
Xuehu LiuZhejiang Provincial Key Laboratory of Resources Protection and Innovation of Traditional Chinese Medicine, College of Food and Health, Zhejiang A & F University, Hangzhou 311300, China.
Wenguang ZhangSchool of Public Health, Jilin Medical University, Jilin, 132013 Jilin, China.
Xiaoyu FengSchool of Public Health, Jilin Medical University, Jilin, 132013 Jilin, China.
Xiaoyao WangSchool of Public Health, Jilin Medical University, Jilin, 132013 Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the effects of carboxymethylation (CM) and combined carboxymethylation-homogenization (CMH) on dietary fiber (DF) from green tea residues. CMH-DF exhibited a significantly higher soluble dietary fiber content (16.07%) and a lower IDF/SDF ratio (3.20) than CM-DF, indicating effective conversion of insoluble fractions. Structural analysis via SEM revealed a looser, more porous architecture in CMH-DF, while FTIR and XRD confirmed successful chemical modification and increased crystallinity. Furthermore, CMH treatment significantly enhanced functional properties, including water-holding and swelling capacities, as well as glucose and cholesterol adsorption. CMH-DF exhibited higher viscosity (0.247 Pa·s) and improved rheological behavior. Increased levels of ellagic acid (3.2-fold), catechin (2.2-fold), resveratrol (2.1-fold), and ferulic acid (2.0-fold) correlated with stronger antioxidant activities (DPPH, ABTS, and FRAP) observed for CMH-DF. These results demonstrate that carboxymethylation combined with homogenization effectively valorizes green tea residue into a multifunctional ingredient with improved techno-functional and health-promoting properties.

Indexed as

Antioxidant activityCarboxymethylationDietary fiberFunctional propertiesGreen tea residueHomogenization

Identifiers

PMID42088279
PMCPMC13138036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.